Initial report of a single institution experience with teclistamab for relapsed or refractory multiple myeloma including prior BCMA

被引：0
|
作者：
Faiman, Beth [1 ]
Dima, Danai [1 ]
Duco, Marissa [1 ]
Rice, Mikhaila [1 ]
Rudoni, Joslyn [1 ]
Anwer, Faiz [1 ]
Khouri, Jack [1 ]
Mazzoni, Sandra [1 ]
Raza, Shahzad [1 ]
Samaras, Christy [1 ]
Williams, Louis [1 ]
Valent, Jason [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-256
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 50 条
  • [21] Outcomes of ide-cel in patients with relapsed/refractory multiple myeloma: A single-institution experience
    Trando, Aaron
    Ghamsari, Farid
    Yeung, Philip
    Costello, Caitlin
    Saunders, Ila M.
    Jeong, Ah-Reum
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience
    Trando, Aaron
    Ghamsari, Farid
    Yeung, Philip
    Costello, Caitlin
    Saunders, Ila
    Jeong, Ah-Reum
    BIOMEDICINES, 2025, 13 (01)
  • [23] Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Hamadeh, Issam S.
    Shekarkhand, Tala
    Rueda, Colin
    Firestone, Ross S.
    Wang, Alice X.
    Korde, Neha
    Hultcrantz, Malin L.
    Lesokhin, Alexander M.
    Mailankody, Sham
    Hassoun, Hani
    Shah, Urvi A.
    Maclachlan, Kylee
    Rajeeve, Sridevi
    Patel, Dhwani
    Shah, Gunjan L.
    Scordo, Michael
    Lahoud, Oscar B.
    Chung, David J.
    Landau, Heather J.
    Giralt, Sergio
    Usmani, Saad Z.
    Tan, Carlyn R.
    BLOOD ADVANCES, 2024, 8 (12) : 3038 - 3044
  • [24] French Monocentric Experience of Outpatient Step-up Dosing of Teclistamab in Relapsed Refractory Multiple Myeloma
    Hebraud, Benjamin
    Granell, Miguel
    Lapierre, Leopoldine
    Mouchel, Pierre Luc
    Beziat, Guillaume
    Sicard, Nina
    Bonneau, Maeva
    Higue, Jules
    Sougy, Florence
    Perriat, Sophie
    Morel, Charlotte
    Bories, Pierre
    Corre, Jill
    Loiseau, Herve Avet
    Recher, Christian
    Perrot, Aurore
    BLOOD, 2023, 142
  • [25] Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
    Davis, James A.
    Snyder, Jordan
    Rice, Mikhaila
    Moore, Donald C.
    Cahoon, Christopher
    Julian, Kelley
    Wagner, Charlotte B.
    Granger, Katelynn
    Green, Kimberly M.
    Atrash, Shebli
    Hill, Hailey
    Mcelwee, Jessica
    Elsey, Grace
    Khouri, Jack
    Rudoni, Joslyn
    Mahmoudjafari, Zahra
    Nachar, Victoria R.
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [26] Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
    Stepanovic, Adam
    Abonour, Rafat
    Abu Zaid, Mohammad
    Farag, Sherif
    Lee, Kelvin P.
    Suvannasankha, Attaya
    BLOOD, 2023, 142
  • [27] Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience
    Uysal, Ayse
    Akad Soyer, Nur
    Ozkan, Melda
    Sahin, Fahri
    Vural, Filiz
    Tobu, Mahmut
    Tombuloglu, Murat
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (01) : 80 - 83
  • [28] Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)
    Maringanti, Sireesha Asoori
    Lin, Yi
    Estritis, Stathis
    Martinez-Lopez, Joaquin
    Bansal, Radhika
    Fotiou, Despina
    Corona, Magdalena
    Chhabra, Saurabh
    Brunaldi, Larissa
    Corraes, Andre De Menezes Silva
    Parrondo, Ricardo
    Kapoor, Prashant
    Ailawadhi, Sikander
    Mas, Reyes
    Tamayo, Andrea
    Dimopoulos, Meletios
    Durie, Brian
    Martin, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S506 - S507
  • [29] BCMA-directed therapy for early relapsed and/or refractory multiple myeloma
    van de Donk, Niels W. C. J.
    Zweegman, Sonja
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (10) : 707 - 708
  • [30] Dexamethasone for the Management of CRS Related to Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma
    Davis, James A.
    Snyder, Jordan
    Rice, Mikhaila
    Moore, Donald C.
    Cahoon, Christopher
    Julian, Kelley
    Wagner, Charlotte B.
    Granger, Katelynn
    Green, Kimberly M.
    Atrash, Shebli
    Hill, Hailey
    Mcelwee, Jessica
    Elsey, Grace
    Khouri, Jack
    Rudoni, Joslyn
    Mahmoudjafari, Zahra
    Nachar, Victoria
    BLOOD, 2024, 144 : 2382 - 2383
12345